Hamilton Wealth’s Medpace MEDP Stock Holding History

Hamilton Wealth’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,179	Closed	-$250K	–	99
2022 Q4	$250K	Buy	+1,179	New	+$236K	0.1%	70

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Hamilton Wealth's MEDP Position: Q1 2023 in Review

Hamilton Wealth sold out of Medpace (MEDP) in Q1 2023, closing a stake of 1,179 shares — an estimated $250K sold.

Hamilton Wealth first reported a position in MEDP in Q4 2022 and held it in 1 quarter. The position peaked at $250K in Q4 2022. 416 funds tracked by Wall St. Rank hold MEDP as of Q1 2023.

Hamilton Wealth reported no remaining Medpace position as of Q1 2023 after selling out during the quarter.
Hamilton Wealth sold 1,179 Medpace shares in Q1 2023, an estimated $250K.
Hamilton Wealth first reported a position in Medpace in Q4 2022 and held it in 1 quarter.
Hamilton Wealth's Medpace position peaked at $250K in Q4 2022.
416 funds tracked by Wall St. Rank held Medpace as of Q1 2023.

Based on Hamilton Wealth's 13F filing for Q1 2023, filed 8 May 2023.